Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
Open Access
- 1 December 2000
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 83 (11) , 1480-1487
- https://doi.org/10.1054/bjoc.2000.1461
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.Journal of Clinical Oncology, 1998
- Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.Journal of Clinical Oncology, 1998
- Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapyBritish Journal of Cancer, 1997
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of Clinical Oncology, 1997
- Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST piBritish Journal of Cancer, 1996
- The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma.1996
- Breast tumour response to primary chemotherapy predicts local and distant control as well as survivalEuropean Journal Of Cancer, 1995
- Locally advanced non-metastatic breast cancer: Analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approachEuropean Journal Of Cancer, 1995
- Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.1995
- Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.Journal of Clinical Oncology, 1995